JNJ vs CAH
By Alex · Tickerpine
Johnson & Johnson vs Cardinal Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | CAH |
|---|---|---|
| Price | $285.75 | $281.10 |
| Market cap | $687.89B | $64.97B |
| P/E ratio | 43.4 | 36.4 |
| ROE | 20.02% | — |
| Profit margin | 16.20% | 0.70% |
| Revenue growth | 5.90% | 5.50% |
| Dividend yield | 1.88% | 0.73% |
| Beta | 0.20 | 0.52 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs CAH in plain English
- JNJ is the bigger company — about 10.6× the market cap of CAH.
- CAH is cheaper on earnings (P/E 36.4 vs 43.4).
- JNJ is growing revenue faster (6% vs 6%).
- JNJ has the higher dividend yield (1.88% vs 0.73%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
CAH return calculator
See what $1,000 in Cardinal Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.